MUNICH — Investigational technology (BioChaperone, Adocia) that enhances the action of already-approved off-patent insulins could improve glycemic control in patients with type 1 and type 2 diabetes, ...

Oral insulin could one day replace injections for people with diabetes, new scientific discoveries suggest. Researchers from Kumamoto University in Japan have announced the development of an insulin ...

Researchers in Canada are developing oral insulin tablets which would replace the necessity of daily injections for patients in need, according to Eurekalert.org. The “game-changing discovery” from ...

Announcing a new publication for Acta Materia Medica journal. The prevalence of diabetes is increasing and expected to become a major global health burden. Various pharmaceutical approaches have been ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for ...

A team of University of British Columbia researchers working on developing oral insulin tablets as a replacement for daily insulin injections have made a game-changing discovery. Researchers have ...

A team of scientists in Canada say they’re a major step closer to creating an easy-to-take oral insulin tablet. In new research, they found that rats dosed with their dissolvable tablet seem to absorb ...

Am J Health Syst Pharm. 2005;62(13):1359-1364. Other pulmonary insulin delivery systems, including ProMaxx, AIR, Spiros, and Technosphere, are also under investigation. ProMaxx uses a proprietary ...

Patients with type 1 diabetes live with a constant risk of hyper- or hypoglycemia. Precisely controlled insulin release could help to improve regulation of their blood sugar levels. In the journal ...

An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of ...

HAMBURG, Germany -- Faster-acting insulin aspart was safe for pregnant women with type 1 or 2 diabetes and resulted in fewer events of hypoglycemia, the randomized CopenFast trial found. The mean ...